Clinical Trial Detail

NCT ID NCT02232243
Title HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Peng Wang
Indications

Advanced Solid Tumor

Therapies

Hydroxychloroquine

Age Groups: adult

No variant requirements are available.